2025 life science report from Munich Re reveals the effects of medications, like Ozempic and Wegovy, on mortality rates and life insurance underwriting.
More From Author
How insurers use AI to judge risks
April 7, 2026
Meet the insurtech: Cyberbay
March 31, 2026
NAIC begins AI evaluation pilot
March 27, 2026
+ There are no comments
Add yours